Characterization of dendritic cells in lip and oral cavity squamous cell carcinoma
- PMID: 26514660
- DOI: 10.1111/jop.12380
Characterization of dendritic cells in lip and oral cavity squamous cell carcinoma
Abstract
Background: There may be differences in the antitumor immunity induced by dendritic cells (DCs) during the development of squamous cell carcinoma (SCC) located in the lip rather than in the oral cavity. The aim of this study was to evaluate the number of immature and mature DCs in SCC and potentially malignant disorders of the oral cavity and lip.
Methods: Immunohistochemistry was used to identify the number (cells/mm(2) ) of immature (CD1a(+) ) or mature (CD83(+) ) DCs in samples of oral cavity SCC (OCSCC) (n = 39), lip SCC (LSCC) (n = 23), leukoplakia (LK) (n = 21), actinic cheilitis (AC) (n = 13), and normal mucosa of the oral cavity (OC control, n = 12) and the lip (lip control, n = 11).
Results: The number of CD1a(+) cells tended to be higher in the OC control samples compared with the LK (P = 0.04) and OCSCC (P = 0.21). Unlike, this cell population was lower in the lip control than in AC or LSCC (P < 0.05). The number of CD83(+) cells was increased in the LSCC samples compared with the AC and lip control (P = 0.0001) and in OCSCC compared with both the LK (P = 0.001) and OC control (P = 0.0001) samples. LSCC showed an elevated number of CD1a(+) and CD83(+) cells compared with OCSCC (P = 0.03). The population of mature DCs was lower than the population of immature DCs in all of the tested groups (P < 0.05).
Conclusion: There were a greater number of both mature and immature DC populations in the LSCC samples than in the OCSCC, which could contribute to establishing a more effective immune antitumor response for this neoplasm.
Keywords: dendritic cell; lip cancer; oral cancer; potentially malignant disorders; squamous cell carcinoma.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
CD1a+ and CD83+ Langerhans cells are reduced in lower lip squamous cell carcinoma.J Oral Pathol Med. 2016 Jul;45(6):433-9. doi: 10.1111/jop.12389. Epub 2015 Dec 12. J Oral Pathol Med. 2016. PMID: 26661374
-
Differential infiltration of CD8+ and NK cells in lip and oral cavity squamous cell carcinoma.J Oral Pathol Med. 2010 Feb;39(2):162-7. doi: 10.1111/j.1600-0714.2009.00792.x. Epub 2009 Sep 14. J Oral Pathol Med. 2010. PMID: 19754647
-
Relevance of HLA-G, HLA-E and IL-10 expression in lip carcinogenesis.Hum Immunol. 2016 Sep;77(9):785-90. doi: 10.1016/j.humimm.2015.12.001. Epub 2015 Dec 23. Hum Immunol. 2016. PMID: 26723902
-
Paying more than lip service to lip lesions.Can Fam Physician. 2003 Sep;49:1111-6. Can Fam Physician. 2003. PMID: 14526863 Free PMC article. Review.
-
Squamous Cell Carcinoma of the Lip-A Review of Squamous Cell Carcinogenesis of the Mucosal and Cutaneous Junction.Dermatol Surg. 2017 Apr;43(4):494-506. doi: 10.1097/DSS.0000000000001020. Dermatol Surg. 2017. PMID: 28157733 Review.
Cited by
-
CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma.Med Oral Patol Oral Cir Bucal. 2020 Jan 1;25(1):e49-e55. doi: 10.4317/medoral.23177. Med Oral Patol Oral Cir Bucal. 2020. PMID: 31880289 Free PMC article.
-
Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity.Dis Markers. 2022 May 19;2022:6389906. doi: 10.1155/2022/6389906. eCollection 2022. Dis Markers. 2022. PMID: 35634436 Free PMC article.
-
Mast cells and factor XIIIa+ dendrocytes in actinic cheilitis and lip squamous cell carcinoma.Braz Oral Res. 2024 Dec 9;38:e113. doi: 10.1590/1807-3107bor-2024.vol38.0113. eCollection 2024. Braz Oral Res. 2024. PMID: 39661794 Free PMC article.
-
Decreased CD1a + and CD83 + cells in tonsillar squamous cell carcinoma regardless of HPV status.J Appl Oral Sci. 2022 May 16;30:e20210702. doi: 10.1590/1678-7757-2020-0702. eCollection 2022. J Appl Oral Sci. 2022. PMID: 35584505 Free PMC article.
-
Different methods of cell quantification can lead to different results: a comparison of digital methods using a pilot study of dendritic cells in HIV-positive patients.Med Oral Patol Oral Cir Bucal. 2020 May 1;25(3):e431-e438. doi: 10.4317/medoral.23472. Med Oral Patol Oral Cir Bucal. 2020. PMID: 32134901 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials